Clear Street’s Bone Biologics Corp Warrants BBLGW Stock Holding History

Clear Street’s Portfolio BBLGW Stock Details BBLGW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-100	Closed	-$1.72K	–	815
2024 Q1	$1.72K	Buy	+100	New	+$1.1K	﹤0.01%	593
2023 Q3	–	Sell	-794	Closed	-$802	–	1141
2023 Q2	$802	Sell	794 -3	-0.4%	-$3	﹤0.01%	1094
2023 Q1	$956	Hold	797	–	–	﹤0.01%	977
2022 Q4	$0	Buy	797 +4	+0.5%	+$7	﹤0.01%	1063
2022 Q3	$2K	Hold	793	–	–	﹤0.01%	945
2022 Q2	$4K	Buy	793 +126	+19%	+$939	﹤0.01%	732
2022 Q1	$7K	Buy	+667	New	+$8.89K	﹤0.01%	280

Other funds holding BBLGW

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Clear Street's BBLGW Position: Q2 2024 in Review

Clear Street sold out of Bone Biologics Corp Warrants (BBLGW) in Q2 2024, closing a stake of 100 shares — an estimated $1.72K sold.

Clear Street first reported a position in BBLGW in Q1 2022 and held it in 7 quarters. The position peaked at $7K in Q1 2022. 2 funds tracked by Wall St. Rank hold BBLGW as of Q2 2024.

Clear Street reported no remaining Bone Biologics Corp Warrants position as of Q2 2024 after selling out during the quarter.
Clear Street sold 100 Bone Biologics Corp Warrants shares in Q2 2024, an estimated $1.72K.
Clear Street first reported a position in Bone Biologics Corp Warrants in Q1 2022 and held it in 7 quarters.
Clear Street's Bone Biologics Corp Warrants position peaked at $7K in Q1 2022.
2 funds tracked by Wall St. Rank held Bone Biologics Corp Warrants as of Q2 2024.

Based on Clear Street's 13F filing for Q2 2024, filed 12 Aug 2024.